novo glp-1 Novo's Wegovy becomes first drug approved for MASH Novo Nordisk's New Oral GLP‑1

Some patients experience postcholecystectomy syndrome, characterized by diarrhea, bloating, or fat malabsorption, which occurs in approximately 10-15% of cases, though prevalence estimates vary

This product is not approved by Health Canada for human or veterinary consumption and is not a drug, medicine, supplement, food, or cosmetic

Hypertension is an independent predisposing factor for heart failure, coronary artery disease, stroke, retinopathy, nephropathy, and peripheral arterial diseases (Sawicka et al., 2011

Tirzepatide is a dual GIP/GLP-1 receptor agonist approved by the FDA for chronic weight management in adults with obesity or overweight with weight-related conditions

Starting at lower doses and increasing gradually helps minimize gastrointestinal symptoms

Will the B12 cause jitters or anxiety like caffeine